Thursday, July 30, 2020

Yale Epidemiologist Accuses Fauci Of 'Misinformation Campaign' Against Hydroxychloroquine; FDA Chief Notes Positive Studies

With the science behind the use of hydroxychloroquine to treat COVID-19 far from settled, more than a few people have noted the aggressive campaign against the widely-prescribed anti-malaria drug.

To that end, Yale epidemiologist Dr. Harvey Risch has accused Dr. Anthony Fouci of waging a "Misinformation campaign" against the drug, according to Just The News.

On Tuesday during an interview on "Good Morning America," Fauci further downplayed the drug's purported benefit, claiming that "The overwhelming prevailing clinical trials that have looked at the efficacy of hydroxychloroquine have indicated that it is not effective in [treating] coronavirus disease."

Risch is sharply criticizing Fauci's approach to evaluating the drug's effectiveness, arguing that repeated trials and tests have shown that it is markedly effective at treating COVID-19 so long as it is administered properly.

On Tuesday, Risch went further, charging in an interview with Just the News that Fauci is perpetrating a "Misinformation campaign" in his opposition to the drug.

Risch said the drug could save 100,000 lives if widely deployed.

Food and Drug Administration Commissioner Stephen Hahn noted that some medical observational studies "Suggest a benefit" to the drug, also according to Just The News.

No comments: